A new report published by the FDA’s Office of Pharmaceutical Quality (OPQ) promises a look at the current “State of Pharmaceutical Quality.” But as AgencyIQ’s analysis shows, there’s much that the report isn’t able to tell us – and more than a few things that are concerning (and potentially misleading) in the report.
FDA’s Office of Pharmaceutical Quality (OPQ)
CDER’s Office of Pharmaceutical Quality became operational in January 2015, making it a still relatively recent addition to the Agency.
Fill out the form to read the full article.
